Phenytoin Sodium Injection is a well-established anticonvulsant drug formulated to prevent and control seizures. This parenteral medication is specifically designed for rapid administration when oral phenytoin administration is not possible. Phenytoin Sodium Inj 250mg/5ml is a critical therapeutic agent in neurology and emergency medicine.
Product Specifications:
- Concentration: 250mg of Phenytoin Sodium per 5ml
- Formulation: Injectable solution
- Volume: 5ml ampoules
- Packaging: Box of 5 ampoules
- Storage: Store at controlled room temperature, away from light and moisture
- Administration: Intravenous or Intramuscular use
Common Applications:
- Management of tonic-clonic (grand mal) seizures
- Prevention and treatment of seizures occurring during or following neurosurgery
- Status epilepticus management
- Cardiac arrhythmias secondary to digoxin toxicity or catecholamine excess
User Groups:
- Neurologists and epileptologists
- Emergency medicine physicians
- Anesthesiologists
- Intensive care specialists
- Cardiologists
Supplier Overview:
Pfizer is a global pharmaceutical leader with an extensive history of innovation and excellence in the development and manufacturing of medications. As a supplier of Phenytoin Sodium Inj 250mg/5ml, Pfizer stands out due to its commitment to quality, safety, and efficacy. With rigorous quality control measures and a robust supply chain, Pfizer ensures that healthcare professionals have access to essential medications like Phenytoin Sodium Injection. Their expertise in the pharmaceutical industry, particularly in the production of neurological and cardiovascular therapies, positions Pfizer as an authoritative figure in the anticonvulsant product space.